Latest Financial Stability News

Assetora Limited has resolved a recent receivership by fully settling its outstanding debt, bringing external administration to a close within a day.

McPherson’s Limited has unveiled a sweeping two-year transformation, streamlining its brand portfolio and adopting a scalable third-party logistics model to drive growth and improve financial stability.

ChemX Materials Limited has emerged from voluntary administration following a Deed of Company Arrangement, while securing a significant Japanese patent for its HiPurA® High Purity Alumina process.

APA Group’s BBB credit rating is affirmed by S&P with a key modification that expands its borrowing power by over $1 billion, positioning the energy infrastructure giant for accelerated growth.

Merino & Co. Limited has unveiled a robust growth plan at its 2025 AGM, highlighting strengthened finances, operational expansion, and a clear focus on sustainability and premium brand positioning in the global apparel market.

Coronado Global Resources has finalized its financial support agreement with Stanwell Corporation, cementing previously disclosed terms and providing clarity on its capital position.

EQ Resources is progressing the refinancing of its €20 million Spanish debt, securing extensions on Oaktree guarantees while negotiating new financing facilities.

Retail Food Group Limited demonstrated resilience in FY25 with slight sales growth and strategic expansions, setting a positive tone for FY26. Key brand innovations and franchisee support underpin its growth trajectory amid leadership transition.

Maggie Beer Holdings reveals strategic progress in its 2025 AGM, focusing on operational simplification, financial stability, and targeted growth for its iconic brands.

Select Harvests has reported a striking turnaround in FY2025, with net profit soaring to $31.8 million driven by higher almond prices and operational efficiency, while halving its net debt.

Dalrymple Bay Infrastructure has declared its Q3-25 distribution consistent with its full-year guidance, reinforcing its commitment to stable returns backed by its key coal export terminal.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.